Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment

Area of Science:

• Hepatology
• Oncology
• Medical Imaging

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
• High recurrence rates (up to 88%) persist even after curative treatments for HCC.
• Accurate staging of recurrent HCC is essential for patient management.

Purpose of the Study:

• To emphasize the necessity of accurate staging for recurrent HCC.
• To identify risk factors associated with poor survival after HCC recurrence.
• To outline current diagnostic and therapeutic strategies for recurrent HCC.

Main Methods:

• Review of identified risk factors for HCC recurrence and survival.
• Discussion of surveillance imaging, particularly magnetic resonance imaging (MRI).
• Analysis of treatment options based on disease status and liver function.

Main Results:

• Key risk factors for poor survival include tumor multifocality, size (≥5 cm), vascular invasion, high AFP, R0 resection, and impaired liver function.
• MRI is preferred for early detection of recurrent HCC.
• Treatment decisions require assessment of extrahepatic disease and liver reserve.

Conclusions:

• Individualized treatment approaches are necessary for recurrent HCC, as a one-size-fits-all strategy is ineffective.
• Options range from repeat resection/ablation for preserved liver function to liver transplantation and multimodality therapy for advanced disease.
• Evidence-based decision-making is vital to optimize outcomes for patients with recurrent HCC.